A Study of JNJ-69095897 in Healthy Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to investigate the safety and tolerability of JNJ-69095897 versus placebo and to characterize the pharmacokinetic (PK) of JNJ-69095897 in blood, plasma, cerebrospinal fluid (CSF) and urine after single or divided oral dose administration in healthy participants.
Epistemonikos ID: 8c911e3079ec154e4253082f707ec81c367b1d57
First added on: May 09, 2024